The DOI matches its Crossref record; 107 of the 114 references it cites were found in a registry or an index.
Predicting the impact of physiological and biochemical processes on oral drug bioavailability
Abstract
Recent advances in computational methods applied to the fields of drug delivery and biopharmaceutics will be reviewed with a focus on prediction of the impact of physiological and biochemical factors on simulation of gastrointestinal absorption and bioavailability. Our application of a gastrointestinal simulation for the prediction of oral drug absorption and bioavailability will be described. First, we collected literature data or we estimated biopharmaceutical properties by application of statistical methods to a set of 2D and 3D molecular descriptors. Second, we integrated the differential equations for an advanced compartmental absorption and transit (ACAT) model in order to determine the rate, extent, and approximate gastrointestinal location of drug liberation (for controlled release), dissolution, passive and carrier-mediated absorption, and saturable metabolism and efflux. We predict fraction absorbed, bioavailability, and C(p) vs. time profiles for common drugs and compare those estimates to literature data. We illustrate the simulated impact of physiological and biochemical processes on oral drug bioavailability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GastroPlus® X (GPX) (Simulations Plus) integrates the Advanced Compartmental Absorption and Transit (ACAT) model with PBPK disposition, with modules for modelling oral absorption and formulation effects.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [93]
In the citing paper
“The integration of allometric scaling with mechanistic absorption, DDI, and elimination modules makes GastroPlus® applicable to FIH dose selection of orally administered drugs and for label-supportive simulations in special populations [93].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [93]
In the citing paper
“Current releases also include a dedicated drug–drug interaction (DDI) module and validated special-population physiologies (pediatric, geriatric, renal- and hepatic-impaired, pregnant), providing capabilities aligned with those of Simcyp®.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [93]
Citations
Cites
Numerical recipes in C: the art of scientific computing
(1993) · Choice Reviews Online · doi:10.5860/choice.30-5638 · Cited by 17,933
Numerical recipes in Pascal: the art of scientific computing
(1990) · Choice Reviews Online · doi:10.5860/choice.27-5158 · Cited by 11,811
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.-P., von Richter, O., Zundler, J., & Kroemer, H. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6663 · Cited by 917
Wacher, V. J., Wu, C., & Benet, L. Z. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940130302 · Cited by 857
Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., & Thummel, K. E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37149-6 · Cited by 789
Lown, K. S., Mayo, R. R., Leichtman, A. B., Hsiao, H.-L., Turgeon, D. K., Schmiedlin-Ren, P., Brown, M. B., Guo, W., Rossi, S. J., Benet, L. Z., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90027-8 · Cited by 680
Lown, K. S., Bailey, D. G., Fontana, R. J., Janardan, S. K., Adair, C. H., Fortlage, L. A., Brown, M. B., Guo, W., & Watkins, P. B. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119439 · Cited by 624
Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data
Iwatsubo, T., Hirota, N., Ooie, T., Suzuki, H., Shimada, N., Chiba, K., Ishizaki, T., Green, C. E., Tyson, C. A., & Sugiyama, Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00184-2 · Cited by 479
ON THE MECHANISM OF INTESTINAL ABSORPTION OF DRUGS
Hogben, C. A. M., Tocco, D. J., Brodie, B. B., & Schanker, L. S. (1959) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12995-9 · Cited by 474
A compartmental absorption and transit model for estimating oral drug absorption
Yu, L. X., & Amidon, G. L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00147-7 · Cited by 455
Research works printed but not linked: 2
- Press, 1992
- Halifax, 1998, Binding of the HIV protease inhibitor saquinavir to human plasma proteins, Br. J. Clin. Pharmacol., 46, 291
Cited by
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
Jones, H., & Rowland‐Yeo, K. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.41 · Cited by 626
When poor solubility becomes an issue: From early stage to proof of concept
Stegemann, S., Leveiller, F., Franchi, D., de Jong, H., & Lindén, H. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.110 · Cited by 567
Pectin-based systems for colon-specific drug delivery via oral route
Liu, L., Fishman, M. L., Kost, J., & Hicks, K. B. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00213-8 · Cited by 553
Metadata
- Authors
- Agoram, B., Woltosz, W. S., & Bolger, M. B.
- Affiliations
- Simulations Plus (United States) (US)
- University of Southern California (US)
- Corresponding author
- Bolger, Michael B.
- ORCID
- Bolger, Michael B.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 50
- Pages
- S41-S67
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2149429360
- Cited by
- 651
- References
- 114
- Citations by year
- 2026: 22 · 2025: 26 · 2024: 19 · 2023: 30 · 2022: 30 · 2021: 46 · 2020: 33 · 2019: 26 · 2018: 26 · 2017: 25 · 2016: 32 · 2015: 43 · 2014: 34 · 2013: 36 · 2012: 37
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- oral bioavailability, gastrointestinal absorption, gastrointestinal tract simulation, biopharmaceutical properties, molecular descriptors, controlled release, drug dissolution, passive absorption, saturable metabolism, efflux, fraction absorbed, pharmacokinetic prediction
- MeSH terms
- Animals, Biological Availability, Computer Simulation, Pharmaceutical Preparations, Humans, Intestinal Absorption, Models, Biological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predicting the impact of physiological and biochemical processes on oral drug bioavailability. https://app.cochat.ai/papers/10.1016/s0169-409x(01)00179-x
- The paper
- Agoram, B., Woltosz, W. S., & Bolger, M. B. (2001). Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Advanced Drug Delivery Reviews. https://doi.org/10.1016/s0169-409x(01)00179-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.